Neuro-oncologie

• CODEL: Phase III Intergroup Study of Radiotherapy versus Temozolomide versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with Newly Diagnosed Anaplastic Oligodendroglioma or Anaplastic Mixed Glioma with Chromosomal co-deletions of 1p and 19q
>>> lees verder 

Medulloblastoma in Adults
>>>lees verder

•WBRT vs. SRS: Whole brain radiotherapy vs. Stereotactic Radiosurgery for 4 – 10 brain metastases:a phase III randomized multicenter trial\
>>> lees verder 

• Chloroquine GBM: A phase I trial for the addition of chloroquine, an autophagy inhibitor, to concurrent chemoradiation for newly diagnosed glioblastoma
>>> lees verder

• M13-813: A Randomized, Placebo Controlled Phase 2b/3 Study of ABT-414 with Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects with Newly Diagnosed Glioblastoma (GBM) with Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance 1)
>>> lees verder

Volg ons op

linkedin youtube